|
SPAST expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.320200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.253200E-01 |
| Normal-vs-Stage2 |
5.315400E-01 |
| Normal-vs-Stage3 |
5.734200E-01 |
| Normal-vs-Stage4 |
6.300200E-01 |
| Stage1-vs-Stage2 |
7.772800E-01 |
| Stage1-vs-Stage3 |
8.788400E-01 |
| Stage1-vs-Stage4 |
9.070000E-01 |
| Stage2-vs-Stage3 |
9.047800E-01 |
| Stage2-vs-Stage4 |
7.412000E-01 |
| Stage3-vs-Stage4 |
8.297400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.545400E-01 |
| Normal-vs-AfricanAmerican |
5.179600E-01 |
| Normal-vs-Asian |
1.446580E-01 |
| Caucasian-vs-AfricanAmerican |
1.415780E-01 |
| Caucasian-vs-Asian |
4.340800E-01 |
| AfricanAmerican-vs-Asian |
1.231440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.593000E-01 |
| Normal-vs-Female |
7.273200E-01 |
| Male-vs-Female |
4.836200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.142800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.306000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.791000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.881600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.064200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.834400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.324400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.736400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.399180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.256590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.971200E-01 |
| Normal-vs-Grade 2 |
1.764770E-01 |
| Normal-vs-Grade 3 |
8.946400E-01 |
| Normal-vs-Grade 4 |
8.420800E-01 |
| Grade 1-vs-Grade 2 |
7.755400E-01 |
| Grade 1-vs-Grade 3 |
6.121600E-01 |
| Grade 1-vs-Grade 4 |
6.897200E-01 |
| Grade 2-vs-Grade 3 |
1.292010E-01 |
| Grade 2-vs-Grade 4 |
2.492800E-01 |
| Grade 3-vs-Grade 4 |
9.049400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.747170E-01 |
| Normal-vs-ccB subtype |
3.616200E-01 |
| ccA subtype-vs-ccB subtype |
8.698800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.800800E-01 |
| Normal-vs-N1 |
1.919800E-01 |
| N0-vs-N1 |
5.617000E-01 |
|
|
